tiprankstipranks
Trending News
More News >
CSPC Pharmaceutical Group Limited (CHJTF)
OTHER OTC:CHJTF
US Market

CSPC Pharmaceutical Group (CHJTF) Income Statement

Compare
27 Followers

CSPC Pharmaceutical Group Income Statement

Last quarter (Q2 2025), CSPC Pharmaceutical Group's total revenue was HK$14.26B, a decrease of -15.15% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was HK$2.74B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
HK$ 29.54BHK$ 31.47BHK$ 31.59BHK$ 27.41BHK$ 23.58B
Gross Profit
HK$ 20.67BHK$ 22.19BHK$ 22.73BHK$ 20.79BHK$ 17.67B
Operating Expenses
HK$ 15.22BHK$ 15.19BHK$ 15.80BHK$ 14.64BHK$ 12.53B
Depreciation and Amortization
HK$ 1.36BHK$ 1.11BHK$ 1.07BHK$ 849.47MHK$ 763.04M
EBITDA
HK$ 7.18BHK$ 8.59BHK$ 8.85BHK$ 7.57BHK$ 6.80B
Operating Income
HK$ 5.45BHK$ 7.01BHK$ 6.93BHK$ 6.14BHK$ 5.14B
Other Income/Expenses
HK$ 229.71MHK$ 388.72MHK$ 811.55MHK$ 591.96MHK$ 904.76M
Pretax Income
HK$ 5.68BHK$ 7.39BHK$ 7.74BHK$ 6.73BHK$ 6.04B
Net Income
HK$ 4.41BHK$ 5.88BHK$ 6.22BHK$ 5.51BHK$ 4.88B
Per Share Metrics
Basic EPS
HK$ 0.38HK$ 0.50HK$ 0.52HK$ 0.46HK$ 0.41
Diluted EPS
HK$ 0.38HK$ 0.49HK$ 0.52HK$ 0.46HK$ 0.41
Weighted Average Shares Outstanding
11.74B 11.87B 11.92B 11.95B 11.95B
Weighted Average Shares Outstanding (Diluted)
11.74B 11.87B 11.92B 11.95B 11.96B
Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History